All News #Library
Others
eXoZymes Joins $9M NSF Cell-Free Bio Program
26 Jun 2025 //
ACCESSWIRE
eXoZymes & MDB Capital Announce Leadership Transition at eXoZymes
21 Feb 2025 //
GLOBENEWSWIRE
Invizyne Tech Announces Name Change to eXoZymes
10 Feb 2025 //
GLOBENEWSWIRE
Invizyne Technologies Announces Closing of Initial Public Offering
14 Nov 2024 //
GLOBENEWSWIRE
Invizyne Technologies Begins Trading on NASDAQ
13 Nov 2024 //
GLOBENEWSWIRE
Invizyne Expands Leadership Ahead of Proposed Nasdaq Listing
06 May 2024 //
GLOBENEWSWIRE
Invizyne Announces Filing of Registration Statement for Proposed Offering
12 Feb 2024 //
GLOBENEWSWIRE
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Cohort
17 Oct 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support